CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on understanding and treating Non-Alcoholic Fatty Liver Disease (NAFLD) through bariatric surgery. By investigating the molecular changes post-surgery, the research aims to identify mechanisms that alleviate NAFLD, independent of weight loss.
Non-Alcoholic Fatty Liver Disease (NAFLD), a disease characterized by accumulation of lipid droplets in the liver, is the major precursor for liver failure and liver cancer, and constitutes a global health challenge.
An estimated 25% of the adult population suffers from NAFLD, but no FDA approved drugs are available to treat this condition.
Obesity is a major NAFLD risk factor and weight-loss improves disease severity in obese patients.
Bariatric surgeries are an effective treatment for obesity…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
